Medicine and Dentistry
Infection
100%
Diagnosis
72%
Pathogen
43%
Glucan
40%
Systemic Mycosis
38%
COVID-19
35%
Disease
30%
Transplantation
30%
Lung Aspergillosis
29%
Polymerase Chain Reaction
26%
Coronavirinae
23%
Hematologic Malignancy
22%
Invasive Aspergillosis
20%
Cerebrospinal Fluid
20%
Colony Forming Unit S
18%
Antifungal Agent
17%
In Vitro
16%
Lung Transplantation
16%
Immunosuppressive Treatment
15%
Sporotrichosis
15%
Pneumocystis Jirovecii
15%
Fungal Meningitis
15%
Immunocompromised Patient
14%
Mycosis
13%
Galactomannan
13%
Central Nervous System
12%
Biological Marker
12%
Fluconazole
11%
Treatment Response
11%
Cystic Fibrosis
10%
Odds Ratio
10%
Nucleic Acid
10%
Human Immunodeficiency Virus
10%
Hazard Ratio
9%
Microbiome
9%
Amphotericin B
9%
Polymerase Chain Reaction
9%
Meningitis
9%
Cross Reaction
9%
Aspergillosis
8%
Antifungal Therapy
8%
Bronchoalveolar Lavage Fluid
8%
Calcofluor-White
8%
Real-Time Polymerase Chain Reaction
8%
Histopathology
8%
Severe Acute Respiratory Syndrome Coronavirus 2
8%
Allograft
8%
Matrix Assisted Laser Desorption Ionization Time of Flight Mass Spectrometry
8%
Mucormycosis
8%
Fungemia
7%
Immunology and Microbiology
Infectious Agent
72%
Polymerase Chain Reaction
52%
Mould
44%
Arthritis
41%
Time-of-Flight Mass Spectrometry
34%
Matrix-Assisted Laser Desorption-Ionization
34%
Cell Wall
31%
Candida Auris
30%
Immunocompromised Patient
28%
Candida
28%
DNA Sequence
25%
Pneumocystis Jiroveci
23%
Electrospray Mass Spectrometry
20%
Aspergillus
19%
Bacterial Cell Wall
18%
Clinical Microbiology
16%
Transplant Procedure
16%
Cryptococcus neoformans
15%
Lactobacillus
15%
Lung Transplantation
15%
Tissue Distribution
15%
Eubacterium
15%
Innate Immune System
15%
Cerebrospinal Fluid
15%
Superoxide
15%
Broth Dilution
15%
Kluyveromyces marxianus
15%
Immunofluorescence
13%
Candida Albicans
12%
Solution and Solubility
12%
Peptidoglycan
12%
Colony Forming Unit S
12%
Prevalence
11%
Filamentous Fungus
11%
Antifungal Susceptibility
11%
Filobasidiella
11%
Mouse
10%
RNA Gene
10%
Agar
10%
Collinsella aerofaciens
9%
Taxon
9%
Cryptococcus gattii
9%
Viral Disease
9%
Aspergillus fumigatus
9%
Normal Human
9%
Chlamydiae
9%
Organismal Interaction
9%
Mycology
9%
Fusarium
9%
Bronchoalveolar Lavage Fluid
8%
Keyphrases
Solid Organ Transplant Recipients
28%
Multidrug-resistant
25%
Confidence Interval
23%
Aurès
23%
Candida Auris
23%
Histoplasmosis
23%
Cerebrospinal Fluid
23%
3-D-glucan
19%
1,3-Dichloropropene (1,3-D)
19%
Cell Wall
18%
Fungal Infection
16%
Invasive Fungal Infection
16%
Laboratory Diagnosis
16%
Pneumocystis Jirovecii
16%
Arthritogenic
16%
Immunocompromised Patients
16%
Bloodstream Infection
15%
COVID-19-associated Pulmonary Aspergillosis
15%
Magnetofluidics
15%
Point-of-care Detection
15%
Fungal Pathogens
15%
Glucan
15%
Arthritis
15%
Candida Kefyr
15%
Clinical Microbiology
15%
Candidemia
14%
Hematological Malignancies
13%
Central Nervous System
12%
Antifungal Susceptibility
12%
Epidemiology
11%
Typing Methods
11%
Progressive Disseminated Histoplasmosis
11%
COVID-19
11%
Risk Factors
10%
United States
10%
Fungi
10%
Filamentous Molds
10%
Fungal Diagnosis
10%
Non-endemic
10%
Voriconazole
9%
Electrospray Ionization Mass Spectrometry
9%
Fungal Diseases
9%
Aspergillosis
9%
Cryptococcosis
9%
Autopsy
9%
Bacteria Identification
9%
Rapid Identification
8%
Invasive Aspergillosis
8%
Echinocandins
8%
Antifungal Drugs
8%
